Carlos Zerrweck

Carlos Zerrweck

Auto-generated profile, based on publicly available information

Carlos Zerrweck

Surgery Department, Centro Médico ABC, Mexico City, Mexico

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2013 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
GDGianluca Donatini
Gianluca Donatini
RCRobert Caiazzo
Robert Caiazzo
CCChristine Do Cao
Christine Do Cao
SASebastien Aubert
Sebastien Aubert
CZCarlos Zerrweck
Carlos Zerrweck
FPFrançois Pattou
François Pattou

16 February 2012 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
CZCarlos Zerrweck
Carlos Zerrweck
VMVincent Maunoury
Vincent Maunoury
RCRobert Caiazzo
Robert Caiazzo
JBJulien Branche
Julien Branche
GDGuélareh Dezfoulian
Guélareh Dezfoulian
FPFrançois Pattou
François Pattou

19 December 2013 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
CZCarlos Zerrweck
Carlos Zerrweck
ESElisa M. Sepúlveda
Elisa M. Sepúlveda
HMHernán G. Maydón
Hernán G. Maydón
FCFrancisco Campos
Francisco Campos
ASAntonio G. Spaventa
Antonio G. Spaventa
IFItzel Fernández
Itzel Fernández

21 February 2018 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
FBFrancisco Barajas-Olmos
Francisco Barajas-Olmos
FCFederico Centeno
Federico Centeno
CZCarlos Zerrweck
Carlos Zerrweck
IIIván Imaz-Rosshandler
Iván Imaz-Rosshandler
AHAngélica Martínez Hernández
Angélica Martínez Hernández
LOLorena Orozco
Lorena Orozco
Obesity is a well-recognized risk factor for insulin resistance and type 2 diabetes (T2D), although the precise mechanisms underlying the relationship remain unknown. In this study we identified alterations of DNA methylation influencing T2D pathogenesis, in subcutaneous and visceral adipose tissues, liver, and blood from individuals with obesity. The study included individuals with obesity, with and without T2D. From these patients, we obtained samples of liver tissue (n = 16), visceral and subcutaneous adipose tissues (n = 30), and peripheral blood (n = 38). We analyzed DNA methylation using Illumina Infinium Human Methylation arrays, and gene expression profiles using HumanHT-12 Expression BeadChip Arrays. Analysis of DNA methylation profiles revealed several loci with differential methylation between individuals with and without T2D, in all tissues. Aberrant DNA methylation was mainly found in the liver and visceral adipose tissue. Gene ontology analysis of genes with altered DNA methylation revealed enriched terms related to glucose metabolism, lipid metabolism, cell cycle regulation, and response to wounding. An inverse correlation between altered methylation and gene expression in the four tissues was found in a subset of genes, which were related to insulin resistance, adipogenesis, fat storage, and inflammation. Our present findings provide additional evidence that aberrant DNA methylation may be a relevant mechanism involved in T2D pathogenesis among individuals with obesity.

21 June 2016 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
OPOmar Pineda
Omar Pineda
HMHernán G. Maydón
Hernán G. Maydón
MAMónica Amado
Mónica Amado
ESElisa M. Sepúlveda
Elisa M. Sepúlveda
LGLizbeth Guilbert
Lizbeth Guilbert
CZCarlos Zerrweck
Carlos Zerrweck

16 October 2015 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
CZCarlos Zerrweck
Carlos Zerrweck
LZLuis Zurita
Luis Zurita
GÁGuillermo Álvarez
Guillermo Álvarez
HMHernán G. Maydón
Hernán G. Maydón
ESElisa M. Sepúlveda
Elisa M. Sepúlveda
LGLizbeth Guilbert
Lizbeth Guilbert